Arrowhead Pharmaceuticals, Inc. logo

Arrowhead Pharmaceuticals, Inc. (ARWR)

$25.02

Arrowhead Pharmaceuticals, Inc. (ARWR) Share Price Forecast
Currently 20 wall-street analysts regularly analyze the financials of Arrowhead Pharmaceuticals, Inc. on a frequent basis to provide recommendations along with target share price. 20 analysts offering 12-month price forecasts for Arrowhead Pharmaceuticals, Inc. (ARWR) have a share price target of $53.77. This median of share price forecast represents a 114.91% upside from the latest price of $25.02 as on 23.05.24.

Arrowhead Pharmaceuticals, Inc. (ARWR) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Arrowhead Pharmaceuticals, Inc. (ARWR) share price will touch around $53.77 in next 12-months.
Arrowhead Pharmaceuticals, Inc. (ARWR) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Arrowhead Pharmaceuticals, Inc.'s share price and its median forecast price. As on 23.05.24, the difference is -56.91%

Arrowhead Pharmaceuticals, Inc. (ARWR): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Arrowhead Pharmaceuticals, Inc. (ARWR) Share Price : Analyst Recommendation
Based on 20 analysts tracking and researching Arrowhead Pharmaceuticals, Inc. (ARWR) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
11
11
11
Outperform
4
4
4
Hold
4
5
5
Underperform
0
0
0
Sell
0
0
0
Arrowhead Pharmaceuticals, Inc. (ARWR) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Arrowhead Pharmaceuticals, Inc. (ARWR) is $53.77, offered by 20 analysts offering 12-month price forecasts.

Arrowhead Pharmaceuticals, Inc. (ARWR) has a maximum of 1.15 upside potential, based on 20 analysts offering 12-month price forecasts.

Based on 20 analysts tracking and researching Arrowhead Pharmaceuticals, Inc. (ARWR), 75% have a buy recommendation. Remaining 25% have either sell or hold recommendations.

The latest share price of Arrowhead Pharmaceuticals, Inc. (ARWR) is $25.02 as of 23/05/2024.

15 of total 20 analysts offering stock ratings for Arrowhead Pharmaceuticals, Inc. ARWR have recommended buy rating.